Koch, Andrea et al
"Symptomatic benefit of olodaterol QD delivered via Respimat® vs placebo and formoterol BID in patients with COPD: Combined analysis from two 48-week studies." European Respiratory Journal
42.Suppl 57
(2013):
P763.
Web. 19 April. 2024.